Chiusura precedente | 70,13 |
Aperto | 70,01 |
Denaro | 0,00 x 800 |
Lettera | 0,00 x 800 |
Min-Max giorno | 69,23 - 70,35 |
Intervallo di 52 settimane | 52,90 - 75,31 |
Volume | |
Media Volume | 244.566 |
Capitalizzazione | 3,482B |
Beta (5 anni mensile) | 0,53 |
Rapporto PE (ttm) | N/D |
EPS (ttm) | -1,61 |
Prossima data utili | 14 mag 2024 |
Rendimento e dividendo (futuro) | N/D (N/D) |
Data ex dividendo | 27 dic 2013 |
Stima target 1A | 75,60 |
TARRYTOWN, N.Y., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 second quarter earnings release on Thursday, November 2, 2023 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com.
TARRYTOWN, N.Y., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Barclays Global Consumer Staples Conference on Thursday, September 7, 2023 at 3:00 p.m. ET. All interested parties may access a live webcast of this event at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations" tab, or by using the following link: https://ir.prestigebrands.com/events-presentations/events For those u
Revenue of $279.3 Million in Q1, up 0.8% versus Prior Year and up 1.8% excluding Foreign CurrencyReduced Leverage Ratio to 3.2x at Quarter End and Completed $25 Million Share Repurchase ProgramReaffirming Full-Year Fiscal 2024 Revenue, Earnings, and Cash Flow Outlook TARRYTOWN, N.Y., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its first quarter ended June 30, 2023. “We are pleased with our first quarter results that delivere